Agoracom Blog Home

Posts Tagged ‘CBD’

Hollister Bioscience’s $HOLL.ca 100% Owned Subsidiary #Venom Extracts Generates Record Monthly Revenue of $3.75 million CDN in May 2020 $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 7:18 AM on Thursday, June 11th, 2020
  • For the month of May 2020, Venom reports that it generated record revenue of CDN$ 3.75 million from its product line of Cannabis Concentrates, P.H.O Concentrates and Cartridges, representing the highest revenue Venom has achieved in a single month
  • As compared to May 2019, Venom’s revenue increased 163%. 

VANCOUVER, BC, June 11, 2020 - Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) ( FRANKFURT: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) a diversified cannabis branding company with products in over 220 dispensaries throughout California, is pleased to announce that its 100% owned subsidiary Venom Extracts (“Venom“) generated record revenue and EBITDA for the month of May 2020. 

For the month of May 2020, Venom reports that it generated record revenue of CDN$ 3.75 million from its product line of Cannabis Concentrates, P.H.O Concentrates and Cartridges, representing the highest revenue Venom has achieved in a single month.  As compared to May 2019, Venom’s revenue increased 163%.  The Company cautions that revenue figures have not yet been audited and are based on reports prepared by Venom management.

“We are firing on all cylinders here at Venom” shared Jake Cohen, Founder of Venom Extracts.  “Having our best month ever in terms of revenue and EBITDA speaks to the resilience of our business model in the face of these uncertain times as well as the healthy customer demand for our product line.”

“We are very excited to see these record monthly revenues. We are looking forward to replicating Venom’s business model in our California facilities and beyond.” shared Carl Saling, CEO of Hollister Biosciences Inc.

About Hollister Biosciences Inc.

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products.  Our wholly-owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Website: www.hollistercannabisco.com

The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

Mota Ventures $MOTA.ca Reports Monthly Revenues of Cdn$5,141,000 for Natures Exclusive, Highest in the History of the Brand $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 8:19 AM on Wednesday, June 10th, 2020
  • Revenue for the month of May totaled Cdn$5,141,000, representing an increase of 110% compared to May 2019
  • 23,141 new customers during the month of May 2020

VANCOUVER, BC, CANADA / ACCESSWIRE / June 10, 2020 / Mota Ventures Corp. (CSE:MOTA) (FSE:1WZ1)(OTC PINK:PEMTF) (the “Company“) the Company’s subsidiary, Nature’s Exclusive, an eCommerce provider of CBD products to consumers in the United States, is pleased to announce an all-time monthly revenue record achieved during May 2020. Revenue for the month of May totaled Cdn$5,141,000, representing an increase of 110% compared to May 2019. Expenses totaled Cdn$4,992,000 for the month, representing a gross profit of Cdn$149,000 for May 2020.

The Company’s investment in customer acquisition continues to yield benefits with the brand acquiring 23,141 new customers during the month of May 2020. The Company’s strong ability to continue to acquire and retain new customers for its products continues to accelerate. As consumers continue to seek natural health product solutions, the Nature’s Exclusive brand is well positioned to offer consumers quality and convenience.

NATURE’S EXCLUSIVE CBD BRAND LEADING THE WAY

The Company’s Nature’s Exclusive brand offers a CBD hemp-oil formulation intended to provide users with the therapeutic benefits that hemp may offer. The hemp oil used in the products is derived from hemp grown and cultivated in the United States. The extraction process is designed to maintain all the beneficial qualities that hemp may offer. Nature’s Exclusive offers a range of products, which include CBD oil drops, CBD gummies, CBD pain relief cream, CBD skin serum and CBD coffee.

“I am very pleased our Nature’s Exclusive brand achieved another monthly sales record. We continued to expand in the United States, and our outlook for the second half of fiscal 2020 is very positive. We remain on track to achieve our goals for 2020 despite the recent economic turmoil,” stated Ryan Hoggan, CEO of the Company.

We encourage readers to visit www.motaventuresco.com to view our brands and sign up to our newsletter.

The Company cautions that figures for revenue, expenses and margin generated from the sale of Nature’s Exclusive products in fiscal year 2020 have not been audited, and are based on calculations prepared by management. Actual results may differ from those reported in this release once these figures have been audited. These figures were translated from US dollars into Canadian dollars using the Bank of Canada monthly average exchange rate of US$1.00:Cdn$1.397 for May 2020 and US$1.00:Cdn$1.3459 for May 2019.

About Mota Ventures Corp.

Mota Ventures is an established eCommerce, direct to consumer provider of a wide range of natural health products including CBD and psychedelic medicine products in the United States and Europe. In the United States, the company sells a CBD hemp-oil formulation derived from hemp grown and formulated in the US through its Nature’s Exclusive brand. Within Europe, its Sativida brand of award winning 100% organic CBD oils and cosmetics are sold throughout Spain, Portugal, Austria, Germany, France, and the United Kingdom. In Germany, Verrian currently produces natural psilocybin extract capsules under the PSI GEN and PSI GEN+ brand. Mota Ventures is also seeking to acquire additional revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.

ON BEHALF OF THE BOARD OF DIRECTORS
MOTA VENTURES CORP.

Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this press release, which has been prepared by management.

Empower $CBDT.ca Launches Covid-19 Testing in Oregon and Provides Support on The Oregon IP34 #Psilocybin Initiative $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:14 AM on Wednesday, June 10th, 2020
  • Empower has commenced phase one and phase two COVID-19 testing in Oregon for existing and new patients, and
  • Supports Oregon ballot IP34 by collecting signatures in its Portland wellness clinic to advance Oregon’s psilocybin therapy initiative

VANCOUVER, BC / June 10th, 2020 / EMPOWER CLINICS INC. (CSE:CBDT) (OTCQB:EPWCF) (Frankfurt:8EC) (“Empower” or the “Company“), a vertically integrated life sciences company, is pleased to announce that Empower has initiated phase one and phase two COVID-19 testing in its Portland, OR clinic. In addition, the Company, in its Portland clinic is successfully collecting signatures for the IP34 ballot for the psilocybin therapy initiative.

“Our team has performed COVID-19 tests for groups and individuals both remotely and inside our clinics as part of our testing program. With national rates of COVID-19 currently spiking, it is critical that we expand our testing services to our large patient base in Oregon.” said Steven McAuley, Chairman & CEO of Empower.

The YES on the IP34 ballot initiative in Oregon has written that psilocybin-assisted therapy is different than the current mental health system; the focus is on treatment and health that doesn’t depend on a lifetime of pills. Rigorous studies at leading medical research institutions such as Johns Hopkins, UCLA, and NYU show that psilocybin is uniquely effective in treating depression, anxiety, trauma like PTSD and addiction. The FDA recently granted a “breakthrough therapy” designation – meaning that psilocybin-assisted therapy may demonstrate substantial improvement over what’s currently available.

“A major aspect of our new psychedelics division, Dosed Wellness, is assisting in the development of new legal markets from the ground up.” said Dustin Klein, SVP Business Development. “We are so pleased that our Portland clinic is a safe location to collect signatures for Oregon’s IP34 ballot initiative.”

Learn more about our new psychedelic’s division at www.dosedwellness.com

ABOUT EMPOWER

Empower is a vertically integrated health & wellness company with a network of corporate and franchised health & wellness clinics in the U.S. The Company is focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has launched Dosed Wellness Ltd. to connect its significant data, to the potential of the efficacy of alternative treatment options related to hemp-derived cannabidiol (CBD) therapies, psilocybin and other psychedelic plant-based treatment options.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

CONTACTS:

Investors: Steven McAuley
Chairman & CEO

[email protected]

604-789-2146

Investors: Dustin Klein
SVP, Business Development

[email protected]

720-352-1398

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release.Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding: the Company’s expected timing of filing of its Annual Filings, the Company’s intention to create psilocybin and psychedelics divisions, that market research on advancements in psilocybin and psychedelics in North America and globally will create greater shareholder value, the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empowers patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond; the ability of the Company to complete or execute phases One, Two, Three or Four of COVID-19 test programs, and Psychedelic substances remain illegal in most countries, so please reference your local laws in relation to medical or recreational use. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

SOURCE: Empower Clinics Inc.

CLIENT FEATURE: TransCanna Holdings $TCAN.ca Developing the Largest Multi-Purpose #Cannabis Facility in California $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 6:08 PM on Monday, June 8th, 2020
tcan-square

(CSE: TCAN) (FSE: TH8)

Why TransCanna?

  • $2M CAD Revenue April 2020
  • $24.6M CAD Revenue Run Rate solely from TransCanna test facility
  • $90M Annual Revenue expected from first full year upon completion of 196,000 Sq Ft Daly facility Q3 2021
  • Daly facility will be one of the largest cannabis facilities in California
  • Recently acquired two California companies,
    • High-end award winning edible producer Soldaze
    • Premium indoor cultivator and distributer Lyfted Farms
  • Lyfted Farms products sold in select Cookies Locations – The most recognizable name in high-end Cannabis.
  • 2019 California Cannabis sales over $3B, industry currently fragmented
  • Direct to dispensary model, cutting out the middleman

THE FACILITY – 196,000 Sq Ft DALY BUILDING

  • Located in Modesto, California; A key asset for TransCanna
  • 196,000 square foot building has an appraised value, prior to licensing and build out, of US $15m.
  • The indicative value once operational, post-licensing and build out is projected at US $80m.
  • Will be the largest multi-purpose cannabis facility in California.
  • Electricity Rates amongst the lowest in California

FULL DISCLOSURE: TransCanna Holdings is an advertising client of AGORA Internet Relations Corp.

Mota Ventures $MOTA.ca Signs Binding Term Sheet to Acquire E-Commerce Platform Leader Unified Funding with C$93.8 Million in Consumer Transactions in 2019 $APH.ca $GBLX $PFE $ACG.ca $ACB.ca $WEED.ca $HIP.ca $WMD.ca $CGRW

Posted by AGORACOM at 11:32 AM on Saturday, June 6th, 2020

June 6, 2020 / Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ:GR)(OTC PINK:PEMTF) (the “Company“) is pleased to announce that it has entered into a binding term sheet (the “Term Sheet“) dated June 5, 2020 with Unified Funding LLC (“Unified“). The term sheet replaces the previous preliminary letter of intent entered into with Unified on May 21, 2020.

Ryan Hoggan, Chief Executive Officer stated “The very nature of CBD, natural health products and psychedelics unequivocally points the future of our nascent industry into digital targeting, marketing and engagement of customers who will turn to the web to learn about and acquire the right products for them. Mota has already demonstrated superior eCommerce capabilities in 2020 but this acquisition of Unified will make us a formidable presence in the space.”

Hoggan added “From a shareholder value point of view, the one thing the biggest tech companies in the world have in common – according to McKinsey – is that they are all platform-based organizations that owe much of their success to the agility with which they are able to innovate and reconfigure themselves to go after new opportunities. With this acquisition, we hope to establish a platform that will serve a growing global industry going forward.”

PLATFORM HAS FACILITATED C$364 MILLION IN TRANSACTIONS SINCE 2015, C$93.8 MILLION IN 2019

Unified is a leading eCommerce platform company established in 2015 by partners with over a decade experience in eCommerce marketing. Unified has developed a proprietary technology platform along with a CRM designed specifically for emerging, small and medium sized eCommerce businesses worldwide. To date, the platform has successfully facilitated over CDN$364,000,000 in consumer transactions, including CDN$93,800,000 in 2019 alone.

The platform generates revenue from licensing, marketing and product fulfillment fees supporting brands in the natural health products sector, including skin care, nutraceutical, essential oils and CBD. Unified brings the platform and experience needed for the Company to expand its product portfolio and brands. Integration of the platform with the Unified experienced team of professionals to run it will allow the Company to develop new products and enter new natural healthcare markets, aided significantly by Unified’s ability to closely track current trends through a global network of media partners.

Kevin Keranen, Chairman of Unified, stated “Along with a diverse team of eCommerce experts, we have built one of the most comprehensive eCommerce platforms in the natural health products sector. Our combination of technology with a full team of individuals dedicated to specific segments of the business allows us to deliver robust growth for our clients. As we look to become a part of Mota, we will be able to access the growth capital to further expand our marketing efforts and support any initiative drive by the Company in a more strategic manner.”

UNIFIED PLATFORM GOES BEYOND PRODUCT SALES

Unified provides a comprehensive suite of managed services in high-demand by its clients. These services are driven by both technology and a team of over forty United States based employees that include:

Customer Acquisition: Unified creates and executes digital marketing campaigns to acquire customers in the clients targeted demographic. By utilizing Unified’s vast marketing channels, clients are able to learn about new market trends and adapt accordingly.

Product Development: Unified is able to guide product development by utilizing intelligence generated by the millions of customer records of opt-in buyers and potential buyers. Unified has relationships with product development professionals, labs and manufacturers to create products within scope and within budget.

Supply Chain Management & Logistics: Through its partners, Unified can help manage clients supply chain to ensure on-time delivery to each customer’s doorstep and to adapt to varying levels of product demand.

Customer Service: As part of the technology platform, Unified provides real-time customer service metrics to accurately measure performance of each customer service agent, which significantly impacts the profitability of each clients business.

Profitability Analysis: Most importantly, the technology and staff at Unified are focused on profitability for each and every client. The business manages over 100 key performance indicators that have been developed through experience, which translates to higher success rates for Unified clients.

PROPOSED TRANSACTION

The Letter of Intent contemplates that the Company would acquire Unified in consideration for US$45,000,000, which will be satisfied through the issuance of common shares of the Company (the “Consideration Shares“). The Consideration Shares will be issuable at a deemed price (the “Transaction Price“) equivalent to the greater of: (i) the volume-weighted average closing price of the common shares of the Company on the Canadian Securities Exchange in the ten trading days prior to the entering into of a definitive agreement in respect of the acquisition, and (ii) Cdn$0.40.

In addition to the Consideration Shares, Unified will be entitled to receive a one-time bonus payment of US$15,000,000 (the “Bonus Payment“) in the event the Company achieves gross revenue in excess of US$15,000,000 from the Unified business in the twelve-month period following closing of the acquisition. The Bonus Payment will be payable in common shares of the Company (the “Bonus Shares“), at the Transaction Price.

The Consideration Shares, and the Bonus Shares, will be subject to terms of a thirty-six month time-release pooling arrangement, during which time they may not be transferred, assigned, pledged or otherwise traded. The shares will be released from the pooling arrangement in tranches, of which twenty percent will be released upon issuance, and the balance in six equal tranches every six months thereafter.

Completion of the proposed acquisition of Unified remains subject to a number of conditions, including, but not limited to, satisfactory completion of due diligence, negotiation of definitive documentation and the receipt of any required regulatory approvals. The acquisition cannot be completed until these conditions are satisfied and there can be no assurance that the acquisition will be completed at all.

The proposed acquisition is not expected to constitute a fundamental change for the Company, nor is it expected to result in a change of control of the Company, within the meaning of applicable securities laws and the policies of the Canadian Securities Exchange. The Company will provide further information regarding the proposed acquisition, as that information becomes available.

This press release is available for investor discussion on the Company’s AGORACOM Discussion Forum, a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.

Figures presented in this news release were translated from US dollars into Canadian dollars using the Bank of Canada closing exchange rate on June 3, 2020 of US$1.00:Cdn$1.3504.

About Mota Ventures Corp.

Mota Ventures is an established eCommerce, direct to consumer provider of a wide range of natural health products including CBD and psychedelic medicine products in the United States and Europe. In the United States, the company sells a CBD hemp-oil formulation derived from hemp grown and formulated in the US through its Nature’s Exclusive brand. Within Europe, its Satavida brand of award winning 100% organic CBD oils and cosmetics are sold throughout Spain, Portugal, Austria, Germany, France, and the United Kingdom. In German Verrian currently produces natural psilocybin extract capsules under the PSI GEN and PSI GEN+ brand. Mota Ventures is also seeking to acquire additional revenue producing CBD brands and operations in both Europe and North America, with the goal of establishing an international distribution network for CBD products. Low cost production, coupled with international, direct to customer, sales channels will provide the foundation for the success of Mota Ventures.

ON BEHALF OF THE BOARD OF DIRECTORS

MOTA VENTURES CORP.
Ryan Hoggan
Chief Executive Officer

For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected] or www.motaventuresco.com

Primo Nutraceuticals Inc.,$PRMO.ca and World Agri Minerals Ltd. Discuss Potential Development of a Proprietary Natural Mineral Blend to Increase Production for Mushroom Growers $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 8:24 AM on Friday, June 5th, 2020
  • Announced that further to its letter of intent with World Agri-Minerals Ltd. , announced in the Company’s news release dated June 4, 2020, Primo and WAM have conducted discussions relating to the development and production of a proprietary mineral blend specially designed for employment by psilocybin mushroom growers
  • Company has identified growing global interest in the potential medical applications of psilocybin and other psychedelic mushrooms
  • WAM claims that their current research and testing will result in benefits similar to those attained when using their already successful GENESIS 89 GOLD blend on Hemp and Cannabis production.

VANCOUVER, British Columbia, June 05, 2020 – PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce that further to its letter of intent (“LOI”) with World Agri-Minerals Ltd. (“WAM”), announced in the Company’s news release dated June 4, 2020, Primo and WAM have conducted discussions relating to the development and production of a proprietary mineral blend specially designed for employment by psilocybin mushroom growers.

The Company has identified growing global interest in the potential medical applications of psilocybin and other psychedelic mushrooms. With world-wide interest in this burgeoning Agri-landscape, WAM is currently developing a new proprietary mineral blend focused on enhancing the production and quality of mushrooms and in particular psychedelic mushroom production. WAM claims that their current research and testing will result in benefits similar to those attained when using their already successful GENESIS 89 GOLD blend on Hemp and Cannabis production. With the new WAM proprietary mineral natural mushroom blend, a healthy more vibrant and 100% organic product can be grown more economically thereby allowing product cost savings for the consumers in addition to enabling growers to be more efficient and profitable. WAM claims that that GENESIS 89 GOLD can increase Hemp and Cannabis productivity anywhere from 15% to 35%. WAM believes that a new mushroom blend could provide similar if not greater production numbers for psilocybin and other mushroom varieties grown for medical applications.

The Mushroom Market

According to the Psychedelic Science Review, the global market for conventional anti-depressants was valued at $13.7 billion in 2016 and is projected to grow to $15.9 billion by 2023.

Andy Jagpal, President Comments:

“We believe that Primo is especially well positioned to capitalize on the emerging ‘shroom boom’ Psilobycin and other varieties of mushrooms are quickly becoming a viable option for mental and physical health treatment. The market for investment opportunity is massive for a nutraceutical company like Primo which has demonstrated its ability to receive NPNs (Natural Product Number) from the Health Products and Food Branch of Health Canada for nutraceutical products.”

About World Agri Minerals Ltd. (WAM)

WAM was formed to actively pursue the manufacturing, marketing and sales of its premiere commercial Agri-product GENESIS 89, an organic plant nutrient that has a proven positive effect on agri-production. WAM now plans to use this same unique blending process to change the way the mushroom industry grows and fertilizes their product. With over 80 trace minerals, GENESIS 89 and GENESIS 89 GOLD contains a proprietary blend that boasts the highest concentration of seawater-harvested minerals available on the commercial and retail market.

About Primo Nutraceuticals Inc.

Primo Nutraceuticals Inc. (“Primo” or the “Company”) is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and non-cannabis related products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoid (CBD) products in both Canada and the United States.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC.

“Andy Jagpal”

President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected]

To learn more about what this news means to the shareholders visit:

Shop: www.primoceuticals.com

www.twitter.com/prmonutra

https://t.me/PrimoNutraceuticals

www.thrivecbd.org

www.beautykitchen.net

www.drinkdefy.com

www.worldagriminerals.com

Corporate: www.primonutraceuticals.com

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. No regulatory authority has approved or disapproved the information contained in this news release.

Hollister Biosciences $HOLL.ca Subsidiary AlphaMind Brands Inc. Plans to Launch Initial Medicinal #Mushroom Based Product Line $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca $FAF.ca

Posted by AGORACOM-JC at 7:10 AM on Thursday, June 4th, 2020
  • Announced that the Company’s 100% owned subsidiary, AlphaMind Brands Inc. plans to launch medicinal mushroom based capsule and powder product lines
  • Initial product line will consist of a blended and bottled powder and capsule consisting of powdered cordyceps, lion’s mane, oyster, reishi and shiitake medicinal mushroom varietals

VANCOUVER, BC, June 4, 2020 - Hollister Biosciences Inc. (CSE: HOLL) (OTCPINK: HSTRF) (Frankfurt: HOB) (the “Company“, “Hollister Cannabis Co.” or “Hollister“) a diversified cannabis branding company with products in over 220 dispensaries throughout California, is pleased to announce that the Company’s 100% owned subsidiary, AlphaMind Brands Inc. (“AlphaMind”) plans to launch medicinal mushroom based capsule and powder product lines.

The initial product line will consist of a blended and bottled powder and capsule consisting of powdered cordyceps, lion’s mane, oyster, reishi and shiitake medicinal mushroom varietals.  The formulations for both products are unique and developed through research driven initiatives.  The health benefits that the capsules and powder intend to provide include but are not limited to anti-inflammatory, antioxidant, anti-aging, anti-microbial and immune system support. 

Raw materials for the product line have arrived at Alphamind’s manufacturing partner, Kirkman and have been sent off for third party testing.  Once the ingredients are approved, AlphaMind anticipates production can begin by mid-June with the aim of having the product line in the market by mid-July 2020. 

Dr. Nikos Apostolopoulos, CSO of AlphaMind shared, “Our AlphaMind five mushroom blend will be a game changer for both athletes and non-athletes alike. This ethically sourced and organically grown blend provides potent antioxidants, and anti-inflammatory responses, helping to improve and maximize performance as well as daily activities.”

About AlphaMind

Alphamind Brands is a Canada and US based growth stage company, that is developing a portfolio of certified legal mushroom based natural health products. It is also actively conducting R&D initiatives, led by Dr. Nikos C. Apostolopoulos, who is exploring psilocybin based pharmaceutical treatments.  The company’s “ready to ship” product SKU’s include Cordyceps, Lion’s Mane, Shiitake, Oyster and Reishi Mushroom based: liquid tinctures, concentrated mushroom powder(s), teas, and chocolate. 

About Hollister

Hollister Biosciences Inc. is a multi-state cannabis company with a vision to be the sought-after premium brand portfolio of innovative, high-quality cannabis & hemp products. Hollister uses a high margin model, controlling the whole process from manufacture to sales to distribution or seed to shelf. Products from Hollister Biosciences Inc. include HashBone, the brand’s premier artisanal hash-infused pre-roll, along with concentrates (shatter, budder, crumble), distillates, solvent-free bubble hash, pre-packaged flower, pre-rolls, tinctures, vape products, and full-spectrum high CBD pet tinctures. Hollister Cannabis Co. additionally offers white-labeling manufacturing of cannabis products.  Our wholly owned California subsidiary Hollister Cannabis Co is the 1st state and locally licensed cannabis company in the city of Hollister, CA birthplace of the “American Biker”.

Website: www.hollistercannabisco.com

The CSE, nor its regulation services provider, does not accept responsibility for the adequacy or accuracy of this release.

Forward-Looking Information: This news release includes certain statements that may be deemed “forward-looking statements”. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “would”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com

VIDEO: Transcanna $TCAN.ca Revenue Run Rate Of $24M Will Increase To $90M When 196,000 Sq Ft Facility Comes Online In 2021

Posted by AGORACOM-JC at 4:04 PM on Wednesday, June 3rd, 2020
tcan-square
  • $2M CAD Revenue April 2020
  • $24.6M CAD Revenue Run Rate solely from TransCanna test facility
  • $90M Annual Revenue expected from first full year upon completion of 196,000 Sq Ft Daly facility Q3 2021
  • Daly facility will be one of the largest cannabis facilities in California
  • Recently acquired two California companies,
    • High-end award winning edible producer Soldaze
    • Premium indoor cultivator and distributer Lyfted Farms
  • Lyfted Farms products sold in select Cookies Locations – The most recognizable name in high-end Cannabis.
  • 2019 California Cannabis sales over $3B, industry currently fragmented
  • Direct to dispensary model, cutting out the middleman

Primo Nutraceuticals Inc. $PRMO.ca Signs Letter of Intent to Enter into Funding and Asset Purchase Agreement with World Agri Minerals Ltd. $CROP.ca $VP.ca NF.ca $MCOA

Posted by AGORACOM-JC at 9:13 AM on Wednesday, June 3rd, 2020
  • Announced that it has signed a non-binding letter of intent to provide funding and to acquire up to 100% of the assets and inventory of World Agri Minerals Ltd.
  • WAM is engaged in the research and development of enhanced production methods using organic plant nutrients and trace minerals found in its GENESIS 89 and GENESIS 89 GOLD product line
  • Products are completed and ready for sales and distribution to growers as a concentrate
  • Product interest has been global

VANCOUVER, British Columbia, June 03, 2020 — PRIMO NUTRACEUTICALS INC. (CSE: PRMO) (OTC: BUGVF) (FSE: 8BV) (DEU: 8BV) (MUN: 8BV) (STU: 8BV) (“Primo” or the “Company”) is pleased to announce that it has signed a non-binding letter of intent (“LOI”) to provide funding and to acquire up to 100% of the assets and inventory of World Agri Minerals Ltd. (“WAM”), together (the “Parties”). WAM is engaged in the research and development of enhanced production methods using organic plant nutrients and trace minerals found in its GENESIS 89 and GENESIS 89 GOLD product line.

WAM was formed to actively pursue the manufacturing, marketing and sales of its premiere commercial agri-product GENESIS 89, an organic plant nutrient that has a proven positive effect on agri-production. WAM now plans to use this same unique blending process to change the way the mushroom industry grows and fertilizes their product. With over 80 trace minerals, GENESIS 89 contains a proprietary blend that boasts the highest concentration of seawater-harvested minerals available on the commercial and retail market.

Current products “GENESIS 89” and “GENESIS 89 GOLD” are completed and ready for sales and distribution to growers as a concentrate. Product interest has been global. As well, several new products are in the research and development phase, not the least of which is a unique blend of trace minerals, similar to that of GENESIS 89 GOLD, designed specifically for the psychedelic mushroom marketplace. WAM is positioned with upward trending organic agri-farming, as well as the medical and recreational hemp/cannabis and psychedelic mushroom industries.

The Parties intend to draft and execute a definitive agreement (the “Definitive Agreement”) with detailed terms as soon as practicable, and complete the transaction on or before June 20, 2020. Terms of the LOI are subject to change as set out in the Definitive Agreement. The final valuation will be determined by an independent third-party evaluator, which is currently in progress.

About Primo Nutraceuticals Inc.

Primo Nutraceuticals Inc. (“Primo” or the “Company”) is dedicated to funding the rapid growth in production, processing, retail and branding of cannabis and non-cannabis related products in Canada and the United States. Primo has invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States. Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of “Primo” branded retail outlets – offering “Thrive,” “Primo,” and a selection of curated partner brands. The Company possesses proprietary formulas for cannabis edibles, topical, and tinctures. Primo is focused on building a strong presence in the hemp industry with the objective of extracting and selling cannabinoid (CBD) products in both Canada and the United States.

On behalf of the Board of Directors

PRIMO NUTRACEUTICALS INC.

“Andy Jagpal”

President and Director

For further information, please contact Zoltan, IR Representative at: 604-722-0305, or; [email protected]

To learn more about what this news means to the shareholders visit:

Shop: www.primoceuticals.com

www.twitter.com/prmonutra

https://t.me/PrimoNutraceuticals

www.thrivecbd.org

www.beautykitchen.net

www.drinkdefy.com

www.worldagriminerals.com

Corporate: www.primonutraceuticals.com

FORWARD LOOKING STATEMENTS: This news release contains certain forward-looking statements within the meaning of Canadian securities laws. Forward-looking statements are based on the expectations and opinions of the Company’s management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. No regulatory authority has approved or disapproved the information contained in this news release.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/77b24a04-64f8-4f81-93b8-737e3a6dbc82

agri-product GENESIS 89
an organic plant nutrient that has a proven positive effect on agri-production

Source: GlobeNewswire (June 3, 2020 – 9:00 AM EDT)

News by QuoteMedia
www.quotemedia.com

TransCanna $TCAN.ca and KeyPLex Collobrate on Innovative Suite of Agro Products to Boost Yield, Treat Plant Pests and Disease $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:14 AM on Wednesday, June 3rd, 2020
tcan-square
  • Entered into a Memorandum of Understanding with major agriculture firm KeyPlex, to create and market high quality bio-pesticides, bio-fungicides, and fertilizers with micronutrients specifically created for the cannabis industry
  • Marks the first time a line of bio-controls and specifically formulated fertilizers designed to increase plant vigor during each stage of the life cycle, will be created for the unique needs of cannabis and hemp crops.

Vancouver, British Columbia–(June 3, 2020) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has entered into a Memorandum of Understanding (“MOU”) with major agriculture firm KeyPlex, to create and market high quality bio-pesticides, bio-fungicides, and fertilizers with micronutrients specifically created for the cannabis industry.

The MOU between the global agricultural powerhouse and Lyfted Farms (a TransCanna subsidiary) marks the first time a line of bio-controls and specifically formulated fertilizers designed to increase plant vigor during each stage of the life cycle, will be created for the unique needs of cannabis and hemp crops. In addition, the all-natural, product lines co-branded by the companies meet the standards required to pass stringent testing in order to be compliant in the highly competitive California cannabis space.

Improving soil and plant health via comprehensive nutritional inputs and biostimulants that make nutrient uptake more effective for cannabis plants has several benefits, including increased yields and disease resistance, and improved pest resistance, which can lead to higher profit margins. In addition, healthier soil requires less water, leading to more sustainable water use and lowered associated costs.

“No one has ever created a similar product range targeting the unique needs of cannabis growers before, so we are pleased to offer a portfolio that will benefit growers and sustainable growing practices in addition to cannabis consumers via high quality and all-natural products,” says Bob Blink, TransCanna CEO. “We are pleased to be working with one of the most respected and largest agriculture brands sharing the same values that we do for sustainable agriculture practices to promote the progressiveness and longevity of our industry.”

“This partnership with KeyPlex,” adds Blink, “to offer cutting edge technology reflects our overall strategy to be innovators in the Cannabis space and to live up to the Lyfted Farms motto of ‘a higher standard of growing.'”

In addition, the products offered through this have no pre-harvest interval, zero worker re-entry restrictions, and have no residual testing limitations.

KeyPlex is a recognized giant in the agriculture industry and global market leader in plant pest and disease control and nutrient input programs. The company was established in 1980 and specializes in sustainable, environmentally friendly, botanically based products that are OMRI certified, EPA exempt, and approved for use in California on all cannabis and hemp varieties. KeyPlex products are currently sold across North America, South America and Europe.

“Lyfted Farms was selected to be our sole partner in this exciting new venture because of its reputation for cultivation expertise and the noted quality of its cannabis flower,” said Gerald O’Connor, CEO of KeyPlex. “We share a passion for innovating and for pushing the standards of quality to meet the needs of producers and with end user safety in mind.”

The first two product offerings are in final-phase development and include a broad-spectrum fungicide and a plant-based insecticide that have demonstrated remarkable effectiveness in repeated crop cycles conducted at Lyfted Farms test facility sites in Modesto, CA.

For more information on this MOU and other TransCanna news please visit us our Agoracom investor community:

https://agoracom.com/ir/TranscannaHoldings/forums/discussion/topics/741323-interview-will-be-live-on-wednesday-june-2nd-at-4pm-est/messages/2268937#message

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a California based, Canadian listed company building Cannabis-focused brands for the California lifestyle, through its wholly-owned California subsidiaries.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at [email protected].

On behalf of the Board of Directors
Bob Blink, CEO
604-349-3011

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.